drugset / Trial / NCT07373613
A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this clinical trial is to evaluate the antihypertensive efficacy and safety of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 with essential hypertension.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR1400-1 | Unknown | — | — |
| Subject | BR1400-2 | Unknown | — | — |
| Subject | BR1400-3 | Unknown | — | — |
| Subject | BR1400-4 | Unknown | — | — |
| Subject | BR1400-5 | Unknown | — | — |